Trial Profile

A Opened, Randomized, Multi-centered Phase II study on the efficacy and safety of CreaVax-HCC(Autologous Mature Dendritic Cells)in patients with hepatocellular carcinoma for comparing after a operation and/or non-operation therapy.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 18 Sep 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Apr 2014 Status changed from active, no longer recruiting to completed as reported by Clinical Research Information Service (CriS) - Republic of Korea.
31 Jul 2013 Planned end date added (30 Sep 2013) as reported by Clinical Research Information Service (CriS) - Republic of Korea.
31 Jul 2013 Status changed from completed to active, no longer recruiting as reported by Clinical Research Information Service (CriS) - Republic of Korea.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com